8.06
Schlusskurs vom Vortag:
$8.15
Offen:
$7.99
24-Stunden-Volumen:
165.19K
Relative Volume:
0.44
Marktkapitalisierung:
$510.34M
Einnahmen:
$198.53M
Nettoeinkommen (Verlust:
$-63.68M
KGV:
-7.885
EPS:
-1.0222
Netto-Cashflow:
$-41.50M
1W Leistung:
-5.71%
1M Leistung:
-9.51%
6M Leistung:
+48.44%
1J Leistung:
-32.58%
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Firmenname
Treace Medical Concepts Inc
Sektor
Branche
Telefon
(904) 373-5940
Adresse
100 PALMETTO PARK PLACE, PONTE VEDRA
Vergleichen Sie TMCI mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
TMCI
Treace Medical Concepts Inc
|
8.07 | 510.34M | 198.53M | -63.68M | -41.50M | -1.0222 |
![]()
ABT
Abbott Laboratories
|
131.47 | 225.32B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
100.30 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
373.42 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
88.44 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
71.91 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-02-04 | Hochstufung | BTIG Research | Neutral → Buy |
2024-12-31 | Eingeleitet | Lake Street | Buy |
2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
2024-05-16 | Herabstufung | UBS | Buy → Neutral |
2024-05-08 | Herabstufung | BTIG Research | Buy → Neutral |
2024-05-08 | Herabstufung | JP Morgan | Overweight → Neutral |
2024-05-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2024-05-08 | Herabstufung | Stifel | Buy → Hold |
2024-05-08 | Herabstufung | Truist | Buy → Hold |
2023-09-29 | Eingeleitet | UBS | Buy |
2023-05-01 | Eingeleitet | Truist | Buy |
2023-04-11 | Eingeleitet | Stephens | Equal-Weight |
2022-05-12 | Eingeleitet | BTIG Research | Buy |
2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2021-05-18 | Eingeleitet | JP Morgan | Overweight |
2021-05-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
2021-05-18 | Eingeleitet | SVB Leerink | Outperform |
2021-05-18 | Eingeleitet | Stifel | Buy |
Alle ansehen
Treace Medical Concepts Inc Aktie (TMCI) Neueste Nachrichten
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Sees Large Decrease in Short Interest - MarketBeat
Quantbot Technologies LP Buys Shares of 9,336 Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $10.14 Consensus Target Price from Analysts - MarketBeat
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $10.14 Average PT from Analysts - Defense World
Charles Schwab Investment Management Inc. Sells 41,523 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
Treace Medical Concepts Studies of Procedures to Treat Mid-Foot Deformities Show Positive Results - Marketscreener.com
Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific Conference - The Manila Times
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Shares Sold by Charles Schwab Investment Management Inc. - Defense World
45,923 Shares in Treace Medical Concepts, Inc. (NASDAQ:TMCI) Bought by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
Bank of New York Mellon Corp Has $937,000 Stock Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace Highlights New Innovations at the 2025 ACFAS Annual Scientific Conference - TradingView
Revolutionary Bunion Treatment: Treace Launches 4 New Minimally Invasive Systems - Stock Titan
45,923 Shares in Treace Medical Concepts, Inc. (NASDAQ:TMCI) Purchased by Connor Clark & Lunn Investment Management Ltd. - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Insider Sean F. Scanlan Sells 50,000 Shares - MarketBeat
Treace Medical Concepts (NASDAQ:TMCI) Trading 4.7% HigherShould You Buy? - MarketBeat
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Sees Large Increase in Short Interest - MarketBeat
William Blair Investment Management LLC Raises Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
Treace Medical Concepts chief innovation officer sells $398k in stock - Investing.com India
Treace Medical Concepts (NASDAQ:TMCI) Price Target Lowered to $9.50 at Truist Financial - MarketBeat
Truist Financial Lowers Treace Medical Concepts (NASDAQ:TMCI) Price Target to $9.50 - Defense World
Treace Medical Concepts (NASDAQ:TMCI) Shares Gap UpStill a Buy? - MarketBeat
John Treace Spends US$524k On Treace Medical Concepts Stock - Yahoo
Rhumbline Advisers Grows Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Truist Financial Forecasts Strong Price Appreciation for Treace Medical Concepts (NASDAQ:TMCI) Stock - MarketBeat
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $10.21 Consensus PT from Analysts - Defense World
Did Treace Medical Concepts, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky InvestigateTMCI - ACCESS Newswire
Treace medical concepts CEO John Treace buys $524,064 in stock By Investing.com - Investing.com South Africa
Treace medical concepts CEO John Treace buys $524,064 in stock - Investing.com
Treace Medical Concepts (NASDAQ:TMCI) Given New $10.00 Price Target at Truist Financial - Defense World
Treace Medical Concepts (NASDAQ:TMCI) Announces Earnings Results - MarketBeat
Treace Medical’s Earnings Call Highlights Growth and Innovation - TipRanks
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2024 Earnings Call Transcript - MSN
Deep Dive Into Treace Medical Concepts Stock: Analyst Perspectives (4 Ratings) - Benzinga
UBS Adjusts Treace Medical Concepts Price Target to $10 From $7.90, Maintains Neutral Rating - Marketscreener.com
Finanzdaten der Treace Medical Concepts Inc-Aktie (TMCI)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):